<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Calcification and ossification of the lungs
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Calcification and ossification of the lungs
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Calcification and ossification of the lungs
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Edward D Chan, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Yael Aschner, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Talmadge E King, Jr, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Paul Dieffenbach, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 11, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H2229025674">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Metastatic and dystrophic calcification, defined as deposition of calcium salts in normal and abnormal tissues, respectively, can manifest in the lungs. Pulmonary ossification refers to bone tissue formation (calcification in a collagen matrix), with or without marrow elements, in the lung parenchyma.
        </p>
        <p>
         While other organs can be affected by ectopic calcification and ossification, the lungs are particularly susceptible [
         <a href="#rid1">
          1
         </a>
         ]. The pathogenesis of lung calcification and ossification is not well understood. Multiple factors contribute to the development of metastatic and dystrophic calcification, including increased serum levels of calcium and phosphate, alkaline phosphatase activity, and local tissue pH [
         <a href="#rid1">
          1,2
         </a>
         ]. It is unlikely that any one physiologic derangement alone is responsible.
        </p>
        <p>
         The etiologies, pathogenesis, clinical manifestations, disorders associated with pulmonary parenchymal calcification and ossification, and potential treatment modalities are reviewed here. An approach to interstitial lung disease is provided separately. (See
         <a class="medical medical_review" href="/z/d/html/4310.html" rel="external">
          "Approach to the adult with interstitial lung disease: Clinical evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4358.html" rel="external">
          "Approach to the adult with interstitial lung disease: Diagnostic testing"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1551579980">
         <span class="h1">
          DEFINITIONS AND CLASSIFICATION
         </span>
        </p>
        <p class="headingAnchor" id="H1922839659">
         <span class="h2">
          Calcification without bone formation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pathological soft tissue calcification without bone formation can be divided into two broad categories, metastatic and dystrophic calcifications, and the rare disorder pulmonary alveolar microlithiasis (
         <a class="graphic graphic_table graphicRef119125" href="/z/d/graphic/119125.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid3">
          3
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Metastatic calcification
         </strong>
         is defined by calcium salt deposition in normal tissues [
         <a href="#rid1">
          1,4
         </a>
         ]. Metastatic pulmonary calcification (MPC) may occur due to both benign and malignant causes, though the most common cause is end-stage kidney disease (ESKD) requiring hemodialysis [
         <a href="#rid5">
          5-7
         </a>
         ]. (See
         <a class="local">
          'Metastatic pulmonary calcification'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dystrophic calcification
         </strong>
         is defined by calcification that occurs in areas of previously injured/abnormal tissue. Dystrophic calcification accounts for the majority of soft tissue calcifications. Prior tissue damage can be due to any number of causes, including infection (mycobacterial, fungal, or viral), noninfectious granulomatous diseases (eg, sarcoidosis), pneumoconioses, amyloidosis, and various fibrotic lung diseases. (See
         <a class="local">
          'Dystrophic calcification'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary alveolar microlithiasis
         </strong>
         <strong>
          (PAM)
         </strong>
         is a rare calcific disorder that is characterized by the intra-alveolar accumulation of round, calcified microliths [
         <a href="#rid1">
          1,8
         </a>
         ]. PAM is caused by mutation of the
         <em>
          SLC34A2
         </em>
         gene encoding the type IIb
         <a class="drug drug_general" data-topicid="10269" href="/z/d/drug information/10269.html" rel="external">
          sodium phosphate
         </a>
         cotransporter in alveolar type II cells [
         <a href="#rid8">
          8
         </a>
         ]. (See
         <a class="local">
          'Pulmonary alveolar microlithiasis'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2905019482">
         <span class="h2">
          Pulmonary ossification
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pulmonary ossification, in contrast to calcification, refers to the formation of mature bone tissue often with marrow elements within the lungs (
         <a class="graphic graphic_table graphicRef119125" href="/z/d/graphic/119125.html" rel="external">
          table 1
         </a>
         ). Ossification can be idiopathic or secondary to a primary pulmonary, cardiac, or extra-cardiopulmonary disorder. (See
         <a class="local">
          'Pulmonary ossification'
         </a>
         below.)
        </p>
        <p>
         Pulmonary ossification can be subdivided into two histologic forms, both of which may be found in the same patient [
         <a href="#rid9">
          9-11
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nodular ossification
         </strong>
         – Nodular ossification is characterized by lobulated bone nodules within alveolar spaces, usually devoid of fat or marrow elements [
         <a href="#rid12">
          12
         </a>
         ]. Nodular ossification usually develops in the setting of passive congestion and pulmonary edema, as from chronic heart failure or valvular abnormalities.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dendriform ossification
         </strong>
         – Dendriform ossification in the lungs is characterized by formation of branching bone tissue that often contains marrow elements. Dendriform ossification preferentially affects the alveolar interstitium and extends through alveolar septae [
         <a href="#rid11">
          11
         </a>
         ]. Dendriform ossification is often associated with underlying fibrotic lung disease, chronic inflammation, or sequelae of acute respiratory distress syndrome but can also be idiopathic in nature [
         <a href="#rid9">
          9,12
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H803582903">
         <span class="h1">
          METASTATIC PULMONARY CALCIFICATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Metastatic pulmonary calcification (MPC) often presents with asymptomatic upper lung zone opacities on chest radiograph. It is important to keep this entity in mind when evaluating chest radiographs of patients with end-stage kidney disease (ESKD) or other predisposing factors to avoid unnecessary diagnostic testing.
        </p>
        <p class="headingAnchor" id="H1601754820">
         <span class="h2">
          Causes and pathogenesis
         </span>
         <span class="headingEndMark">
          —
         </span>
         MPC occurs most commonly in ESKD patients on hemodialysis [
         <a href="#rid4">
          4,5,13,14
         </a>
         ]. Most other causes are rare but include orthotopic liver transplantation, primary hyperparathyroidism, hypervitaminosis D, parathyroid carcinoma, and multiple myeloma, among others [
         <a href="#rid1">
          1,15-17
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Renal failure
         </strong>
         – In patients with ESKD, particularly those on hemodialysis, acidosis and secondary hyperparathyroidism increase calcium and phosphate release from bone, while intermittent alkalosis (absolute or relative) during hemodialysis provides a milieu that is conducive for calcium salt precipitation in soft tissues. Decreased glomerular filtration of phosphate also contributes to elevations in calcium-phosphate product [
         <a href="#rid1">
          1,2,15,18,19
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Orthotopic liver transplantation
         </strong>
         – MPC may also occur following orthotopic liver transplantation. The mechanism underlying this phenomenon is unclear, though concurrent renal failure, acid-base abnormalities, or administration of exogenous citrate from fresh frozen plasma used to treat coagulopathy may contribute. The resulting high plasma citrate levels result in alkalosis as citrate is metabolized to bicarbonate ion (HCO
         <sub>
          3
         </sub>
         <sup>
          -
         </sup>
         ) and in chelation of ionized calcium, which stimulates release of parathyroid hormone and subsequent deposition of calcium in soft tissues [
         <a href="#rid16">
          16,20
         </a>
         ]. Cases have also been reported following renal transplantation [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Malignancy with hypercalcemia
         </strong>
         – MPC can accompany a variety of malignancies that are associated with hypercalcemia and/or elevated calcium-phosphate product. In these cases, hypercalcemia may be hormonally mediated or driven by bone lysis due to cancer metastases to the bones. Even in these cases of malignancy, the development of MPC is rare, which may be due, in part, to the generally poor prognosis associated with metastatic cancer [
         <a href="#rid2">
          2,22
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Overall, the pathogenesis of MPC is mediated by excess serum calcium, an elevated calcium-phosphate product, and an alkaline environment.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Excess calcium
         </strong>
         – While metastatic calcification can occur at normal serum calcium levels, the process is favored by an elevated calcium-phosphate product &gt;70 mg
         <sup>
          2
         </sup>
         /dL
         <sup>
          2
         </sup>
         (normal is approximately 40 mg
         <sup>
          2
         </sup>
         /dL
         <sup>
          2
         </sup>
         ) [
         <a href="#rid2">
          2,13
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Factors in chronic hemodialysis patients, the most common at-risk group, that result in increased calcium-phosphate product include periodic acidosis that leaches calcium from bone, secondary/tertiary hyperparathyroidism, uremia, and hyperphosphatemia [
         <a href="#rid2">
          2
         </a>
         ]. In cases of MPC with a normal calcium-phosphate product, a sensitizing or predisposing condition, such as elevated parathyroid hormone, exogenous vitamin D, or azotemia, may be required to prime the tissue for pulmonary calcification [
         <a href="#rid1">
          1,2,23
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Alkaline environment
         </strong>
         – Calcium salts precipitate under alkaline conditions. Notably, organs that are susceptible to metastatic calcification, such as the stomach, kidneys, and the lungs, secrete free hydrogen ions, creating a relatively alkaline tissue environment [
         <a href="#rid2">
          2,24
         </a>
         ]. This mechanism may explain why the lung apices are more affected by MPC than the bases; ie, the higher ventilation-perfusion ratio in the apex results in lower end-capillary partial pressure of arterial carbon dioxide (PaCO
         <sub>
          2
         </sub>
         ), and therefore a higher pH as compared with the lung base [
         <a href="#rid25">
          25
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Alkalosis alone may not be sufficient to develop ectopic calcification, but in synergy with other risk factors, it can promote deposition of calcium. For example, the relative alkalosis following hemodialysis, along with other aforementioned risk factors associated with ESKD, may contribute to this condition [
         <a href="#rid5">
          5
         </a>
         ]. The milk-alkali syndrome, which is much less commonly seen now, can also cause metastatic calcification due to a combination of high blood calcium and metabolic alkalosis [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Among five patients with localized MPC, the calcification occurred distal to or adjacent to sites of pulmonary artery occlusion by thrombus or tumor [
         <a href="#rid27">
          27
         </a>
         ]. While the lung tissues also had variable areas of infarction, pneumonia, and/or diffuse alveolar damage, MPC did not necessarily occur in these abnormal areas of the lungs and thus could not be classified solely to dystrophic calcifications. Possibly, local tissue alkalosis distal to the site of the pulmonary artery occlusion – from the combination of hyperventilation reducing the partial pressure of alveolar carbon dioxide (PaCO
         <sub>
          2
         </sub>
         ) and impaired blood flow decreasing delivery of PaCO
         <sub>
          2
         </sub>
         – enabled a more alkaline environment that favored calcium salt precipitation [
         <a href="#rid27">
          27
         </a>
         ]. This is a reasonable hypothesis since the lungs receive oxygen supply from the bronchial artery branches and directly from the alveoli as well as blood from the pulmonary artery and thus are resistant to hypoxic-ischemia-induced anaerobic metabolism and lactic acidosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Additionally, alkaline phosphatase, an enzyme that catalyzes the production of free phosphate and thereby elevates the calcium-phosphate product, has maximal activity at an alkaline pH [
         <a href="#rid28">
          28
         </a>
         ]. Alkaline phosphatase also enhances osteoblastic activity and thus may play a role in the process of pulmonary ossification as well [
         <a href="#rid9">
          9,29
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2066593938">
         <span class="h2">
          Clinical presentation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with MPC are often asymptomatic or may have symptoms related to their underlying disease. The clinical finding leading to a diagnosis of MPC tends to be a chest radiograph with upper lung zone opacities.
        </p>
        <p>
         MPC generally does not compromise lung function, although severe cases have been described [
         <a href="#rid1">
          1,2,18,30
         </a>
         ]. In patients with extensive MPC, restrictive physiology, decreased diffusion capacity, or hypoxemia may result. Rarely, progressive respiratory insufficiency and death may occur [
         <a href="#rid2">
          2,7,31,32
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3348122984">
         <span class="h2">
          Evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         The evaluation of suspected MPC includes measurement of serum calcium and phosphate, assessment of pulmonary function, and review of imaging for characteristic features. Bone scintigraphy is occasionally needed to confirm the diagnosis.
        </p>
        <p class="headingAnchor" id="H3436230021">
         <span class="h3">
          Laboratory testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with ESKD, MPC is usually associated with elevated serum calcium and/or phosphate levels or calcium-phosphate product, as seen with tertiary hyperparathyroidism after long-standing stimulation of the parathyroid glands from secondary hyperparathyroidism. For patients with MPC associated with malignancy, serum parathyroid hormone may be elevated. In patients with clinical manifestations of primary hyperparathyroidism, an elevated parathyroid hormone in the setting of increased serum calcium level and reduced phosphate level is highly suggestive. (See
         <a class="medical medical_review" href="/z/d/html/2055.html" rel="external">
          "Parathyroid hormone assays and their clinical use", section on 'Clinical use of PTH assays'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2605912026">
         <span class="h3">
          Pulmonary function testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         When evaluating patients with suspected MPC, we typically obtain spirometry, plethysmographic lung volumes, diffusing capacity for carbon monoxide (DLCO), and six-minute walk testing with oximetry. The degree of physiologic impairment does not necessarily correlate with the degree of calcification seen on imaging studies; some patients with extensive calcification may be asymptomatic, while others with minimal visible calcification may have significant physiologic impairment, likely due to underlying or concomitant lung disorders [
         <a href="#rid1">
          1,25
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2058045031">
         <span class="h3">
          Imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         A chest radiograph is generally useful for detection of pleural, hilar, or mediastinal lymph node, or lung nodule calcification, but is relatively insensitive for identification of lung parenchymal calcification. The appearance of upper lung zone opacities can often be mistaken for other conditions such as bronchiectasis, fibrosis, or edema [
         <a href="#rid25">
          25,31
         </a>
         ].
        </p>
        <p>
         High-resolution computed tomography (HRCT) scans are more sensitive and specific than chest radiographs for the detection of pulmonary calcification [
         <a href="#rid33">
          33-37
         </a>
         ]. Densitometry measurements of thin-slice (1 mm) HRCT confirm the high attenuation characteristic of calcified tissue even though calcification may not be apparent visually [
         <a href="#rid33">
          33,38
         </a>
         ]. Thus, it is worth emphasizing that when the calcification is microscopic, CT images may not reveal areas of calcification, particularly if standard 7- or 10-mm-thick images are obtained [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
         Three HRCT patterns of metastatic pulmonary calcification can be seen, and these patterns may be present simultaneously in a given patient [
         <a href="#rid33">
          33-35,39
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Multiple calcified nodules in a diffuse or localized distribution
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diffuse or patchy areas of ground glass opacification
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dense area(s) of consolidation that mimic a lobar pneumonia
        </p>
        <p>
        </p>
        <p>
         Additional radiographic findings may include calcification of the tracheobronchial walls or chest wall blood vessels or a "ring" pattern of nodular calcification, particularly with MPC due to ESKD [
         <a href="#rid39">
          39
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4114600141">
         <span class="h3">
          Bone scintigraphy
         </span>
         <span class="headingEndMark">
          —
         </span>
         In equivocal cases, bone scintigraphy with the bone-avid radiotracer
         <sup>
          99m
         </sup>
         technetium-methylene diphosphate (
         <sup>
          99m
         </sup>
         Tc-MDP) may help distinguish pulmonary calcification from other conditions such as pneumonia or pulmonary edema [
         <a href="#rid25">
          25,37,40-42
         </a>
         ]. Several cases have been reported of positive pulmonary bone scintigraphy without chest radiographic evidence of calcification [
         <a href="#rid43">
          43,44
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H275217988">
         <span class="h2">
          Diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of MPC can often be made on the basis of HRCT scan [
         <a href="#rid33">
          33-37
         </a>
         ]. When the HRCT findings are not diagnostic,
         <sup>
          99m
         </sup>
         Tc-MDP scanning can confirm the diagnosis.
        </p>
        <p class="headingAnchor" id="H2743196437">
         <span class="h2">
          Treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         In MPC, specific conditions that elevate the calcium-phosphate product should be corrected to prevent further calcification [
         <a href="#rid1">
          1,45
         </a>
         ]. Renal transplantation for patients with ESKD often mitigates this process [
         <a href="#rid46">
          46
         </a>
         ]. In some cases, however, MPC persists and progresses even with a functioning transplanted organ; some of these cases may be due to tertiary hyperparathyroidism [
         <a href="#rid21">
          21,47
         </a>
         ]. In such severe cases, parathyroidectomy may be indicated [
         <a href="#rid21">
          21,45
         </a>
         ].
        </p>
        <p>
         Spontaneous resolution of MPC has also been described, though it is rare [
         <a href="#rid45">
          45,48
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1405257393">
         <span class="h1">
          DYSTROPHIC CALCIFICATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Dystrophic calcification in the lungs occurs in areas where the tissue has become altered, necrotic, or otherwise nonviable. Dystrophic calcification requires tissue injury and repair for calcification to occur [
         <a href="#rid1">
          1,25
         </a>
         ].
        </p>
        <p>
         Granulomatous diseases such as fungal infections, tuberculosis, or sarcoidosis can result in calcification in the setting of normal serum calcium levels. Excess production of 1,25 vitamin D by macrophages increases intestinal calcium and phosphate absorption, even in the absence of rising serum calcium concentration [
         <a href="#rid49">
          49,50
         </a>
         ]. Serum levels of calcium and phosphate are normal [
         <a href="#rid1">
          1,3
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/841.html" rel="external">
          "Hypercalcemia in granulomatous diseases"
         </a>
         .)
        </p>
        <p>
         Imaging evidence of dystrophic calcification is frequently an incidental finding and may be completely asymptomatic [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
         The diagnosis is typically made based on the chest high-resolution computed tomography (HRCT) appearance [
         <a href="#rid20">
          20,51
         </a>
         ].
        </p>
        <p>
         Dystrophic calcification due to infection or other lung disease is treated by targeting the underlying disease process.
        </p>
        <p class="headingAnchor" id="H3463367868">
         <span class="h2">
          Pulmonary calcification due to infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Many microbial infections can predispose to the development of pulmonary calcification. Infections that generate a granulomatous tissue response, such as those due to
         <em>
          Histoplasma capsulatum
         </em>
         ,
         <em>
          Coccidioides immitis
         </em>
         , or
         <em>
          Mycobacterium tuberculosis
         </em>
         , can result in intrathoracic dystrophic calcifications [
         <a href="#rid1">
          1
         </a>
         ]. Viral (eg, varicella) and parasitic (eg,
         <em>
          Paragonimus westermani
         </em>
         ) infections can also result in pulmonary calcification [
         <a href="#rid1">
          1
         </a>
         ]. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Histoplasma
         </em>
         infections can result in calcified mediastinal lymph nodes, broncholithiasis, mediastinal granuloma, and solitary or multiple calcified histoplasmomas [
         <a href="#rid52">
          52-54
         </a>
         ].
         <em>
          Pneumocystis jirovecii
         </em>
         infections in HIV-positive patients can lead to pulmonary or thoracic lymph node calcifications, and diffuse visceral calcification in disseminated disease [
         <a href="#rid55">
          55-57
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tuberculosis can produce dystrophic calcifications in the form of parenchymal granulomas, mediastinal lymph node calcification, and/or calcified fibronodular areas of lung [
         <a href="#rid54">
          54
         </a>
         ]. Diffuse nodular calcification of the lungs may follow miliary infections [
         <a href="#rid58">
          58
         </a>
         ]. Patients with tuberculosis can also develop hypercalcemia due to excessive production of endogenous 1,25 vitamin D that predisposes to further calcification [
         <a href="#rid59">
          59
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/841.html" rel="external">
          "Hypercalcemia in granulomatous diseases"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Varicella pneumonia can present with scattered reticular or nodular densities (
         <a class="graphic graphic_diagnosticimage graphicRef70236" href="/z/d/graphic/70236.html" rel="external">
          image 1
         </a>
         ). These usually resolve with time but can result in asymptomatic miliary calcifications years after the acute event (
         <a class="graphic graphic_diagnosticimage graphicRef50429" href="/z/d/graphic/50429.html" rel="external">
          image 2
         </a>
         ) [
         <a href="#rid60">
          60,61
         </a>
         ]. Delayed development of pulmonary calcification after smallpox virus exposure has been reported [
         <a href="#rid62">
          62,63
         </a>
         ]. Other DNA viruses, such as herpes simplex, have been described to cause pulmonary calcifications [
         <a href="#rid64">
          64
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Several parasitic infections can manifest with calcification in the lungs.
         <em>
          Paragonimus westermani
         </em>
         infections can cause pleural and lung parenchymal calcification, which is thought to be due to calcified mummification of the parasites and their eggs [
         <a href="#rid65">
          65
         </a>
         ]. A calcified rim is sometimes seen with pulmonary and mediastinal echinococcal cysts [
         <a href="#rid66">
          66-68
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2810658255">
         <span class="h2">
          Pulmonary calcification associated with other lung diseases
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pulmonary amyloidosis and sarcoidosis are examples of noninfectious diseases associated with pulmonary calcification. The clinical setting and radiographic appearance may be sufficient for diagnosis.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary amyloidosis
         </strong>
         – Primary amyloidosis occurs in the setting of aberrant production and deposition of mostly light-chain amyloid protein in tissues. Secondary calcification of amyloid fibrils may occur due to their affinity for calcium [
         <a href="#rid69">
          69
         </a>
         ]. The airways and lung parenchyma are frequently affected sites of disease in patients with primary amyloidosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         When calcification occurs, the typical radiographic appearance includes mixed interstitial and alveolar opacifications with varying degrees of calcification in the mid- and lower subpleural regions (
         <a class="graphic graphic_diagnosticimage graphicRef87611" href="/z/d/graphic/87611.html" rel="external">
          image 3
         </a>
         ); ossification is rare [
         <a href="#rid70">
          70,71
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sarcoidosis
         </strong>
         – Lung parenchymal sarcoidosis rarely results in micronodular calcifications that appear similar to pulmonary alveolar microlithiasis (PAM) on imaging studies [
         <a href="#rid72">
          72
         </a>
         ] . Whereas the calcification in sarcoidosis is localized to epithelioid granulomas, distinct intra-alveolar microliths are seen in PAM on lung microscopy [
         <a href="#rid1">
          1
         </a>
         ]. (See
         <a class="local">
          'Pulmonary alveolar microlithiasis'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1976556386">
         <span class="h1">
          PULMONARY ALVEOLAR MICROLITHIASIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pulmonary alveolar microlithiasis (PAM) is a rare, autosomal recessive disorder, characterized by widespread deposition of calcium phosphate microliths throughout the lungs (MIM: #265100) [
         <a href="#rid8">
          8,73,74
         </a>
         ]. It occurs in the absence of disorders of calcium metabolism. PAM is found worldwide but has the highest prevalence in Turkey, Japan, and Italy [
         <a href="#rid8">
          8
         </a>
         ]. Just over one-third of cases are familial, and there is a high rate of consanguinity among parents of affected patients, which suggests an underlying autosomal recessive disease with high penetrance [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3673125199">
         <span class="h2">
          Pathophysiology
         </span>
         <span class="headingEndMark">
          —
         </span>
         In 2006, the gene responsible for PAM,
         <em>
          SLC34A2
         </em>
         at
         <em>
          4p15.2
         </em>
         , was identified independently by groups in Japan and Turkey. The gene variants in nearly all patients who have been studied lead to abnormal or abolished gene function [
         <a href="#rid8">
          8,75-78
         </a>
         ]. To date, over 30
         <em>
          SLC34A2
         </em>
         variants have been identified [
         <a href="#rid79">
          79,80
         </a>
         ].
        </p>
        <p>
         The
         <em>
          SLC34A2
         </em>
         gene encodes a type IIb sodium-dependent phosphate transporter that has essential roles in the homeostasis of inorganic phosphate. It is the only phosphate transporter that is highly expressed in the lung and is found in type II alveolar cells (ATII), which make and degrade surfactant, a major component of which is phospholipid. The protein functions to transport phosphate ion from degraded phospholipids in alveoli into ATII cells. When the sodium-dependent phosphate transport protein 2B is dysfunctional, ATII cells are unable to clear phosphate ion from the alveolar space, resulting in the formation of microliths [
         <a href="#rid81">
          81,82
         </a>
         ]. Studies suggest that the severity of disease may be associated with specific variants in the
         <em>
          SLC34A2
         </em>
         gene [
         <a href="#rid83">
          83
         </a>
         ].
        </p>
        <p>
         While
         <em>
          SLC34A2
         </em>
         is also expressed in other organs, microliths usually do not form due to the presence of redundant ion transporters, accounting for the low incidence of extrapulmonary manifestations of PAM [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H730117760">
         <span class="h2">
          Clinical manifestations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most patients with PAM (88 percent) are under the age of 50 years, with approximately 35 percent under the age of 20 at time of diagnosis [
         <a href="#rid84">
          84
         </a>
         ]. Despite dramatic imaging findings, most patients are asymptomatic at the time of diagnosis, and PAM is often found incidentally during imaging studies performed for another reason, or screening of family members of affected patients [
         <a href="#rid85">
          85
         </a>
         ]. When symptoms develop, they usually occur in the third or fourth decade, although presentation over age 60 has been reported [
         <a href="#rid86">
          86
         </a>
         ]. However, children who present at age five years or younger are more likely to be symptomatic and present with cough and severe acute respiratory failure [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p>
         In a large series identified by literature review, a family history of PAM was identified in one-third [
         <a href="#rid85">
          85
         </a>
         ]. Symptoms included dyspnea (24 percent), nonproductive cough (14 percent), chest pain (6 percent), and asthenia (3 percent).
        </p>
        <p class="headingAnchor" id="H1347294265">
         <span class="h2">
          Evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Imaging studies are key to the diagnosis; laboratory tests are usually normal.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Laboratory testing
         </strong>
         – Serum calcium and phosphorus levels are usually normal [
         <a href="#rid88">
          88
         </a>
         ]. While a next generation sequencing test for
         <em>
          SLC34A2
         </em>
         is commercially available (
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fulgentgenetics.com%2FPulmonary-Alveolar-Microlithiasis&amp;token=DzPMsBhauzgvZzN%2FvOiltd5bn%2BTNeic2vgWNQPGhN9A50TPiMbGBR01zSKdN4tuNA8aSAQX9jcDZPdyScIx54qvM0lT8d4cbwFumhkeMEfg%3D&amp;TOPIC_ID=117030" target="_blank">
          https://www.fulgentgenetics.com/Pulmonary-Alveolar-Microlithiasis
         </a>
         ), imaging studies are so characteristic that genetic testing is generally not required to make the diagnosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary function tests
         </strong>
         – Pulmonary function tests (PFTs) are obtained at intervals to identify and monitor respiratory impairment. PFTs may be normal initially and later show a restrictive pattern with reduced diffusion capacity [
         <a href="#rid1">
          1,82
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Imaging
         </strong>
         – The chest radiograph shows a "sandstorm" appearance of diffuse scattered micronodules with a predilection for the lung bases, often obscuring the contours of the heart and diaphragm [
         <a href="#rid85">
          85,89,90
         </a>
         ]. In children, ground glass opacities are frequent while calcifications are fewer, smaller, and mainly restricted to the lower lobes [
         <a href="#rid87">
          87
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         HRCT reveals micronodular calcifications primarily located along bronchovascular bundles, and subpleural and perilobular regions [
         <a href="#rid85">
          85,89,91-93
         </a>
         ]. Diffuse ground glass opacities are often present [
         <a href="#rid94">
          94
         </a>
         ]. Calcific thickening of the interlobular septa may be seen, as well as subpleural cystic changes [
         <a href="#rid48">
          48,78,82
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Tc-99m methylene diphosphonate (MDP) whole-body bone scintigraphy may also be employed in the case of unclear standard imaging. Scans will show widespread involvement in the lungs [
         <a href="#rid95">
          95
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Flexible bronchoscopy
         </strong>
         – While bronchoscopy is usually not needed for diagnosis, bronchoalveolar lavage (BAL) and transbronchial biopsy can be useful if the diagnosis is uncertain. Lamellar microliths have been identified in lavage fluid and on transbronchial biopsy [
         <a href="#rid85">
          85
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H805816017">
         <span class="h2">
          Diagnosis and differential diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of PAM can usually be determined by the imaging findings showing a classic “sandstorm” with obscuration of the cardiac borders and micronodular calcifications bronchovascular bundles, subpleural and perilobular regions [
         <a href="#rid85">
          85,89
         </a>
         ]. BAL and/or transbronchial biopsy can confirm intra-alveolar lamellar microliths [
         <a href="#rid82">
          82,96
         </a>
         ]. Lung biopsy is rarely needed, particularly in a family with a known affected member.
        </p>
        <p>
         The differential diagnosis includes the following processes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         PAM can be differentiated from diffuse pulmonary ossification based on the larger size of the nodules in pulmonary ossification and the typical underlying disease processes (eg, chronic pulmonary venous congestion, idiopathic pulmonary fibrosis). (See
         <a class="local">
          'Pulmonary ossification'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Metastatic pulmonary calcification has a strong upper lung zone predilection and usually develops in patients with end-stage kidney disease (ESKD), thus making it easy to differentiate from PAM. (See
         <a class="local">
          'Metastatic pulmonary calcification'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sarcoidosis rarely presents with diffuse micronodular calcifications. On histopathology, the calcification in sarcoidosis is localized to epithelioid granulomas, while distinct intra-alveolar microliths are seen in PAM. (See
         <a class="medical medical_review" href="/z/d/html/4353.html" rel="external">
          "Clinical manifestations and diagnosis of sarcoidosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other diseases associated with parenchymal calcification, such as tuberculosis, idiopathic pulmonary hemosiderosis, pneumoconiosis (eg, silicosis), and nodular amyloidosis can be considered in the diagnosis. (See
         <a class="medical medical_review" href="/z/d/html/7026.html" rel="external">
          "Pulmonary tuberculosis: Clinical manifestations and complications", section on 'Radiologic findings'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4318.html" rel="external">
          "Idiopathic pulmonary hemosiderosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4321.html" rel="external">
          "Silicosis"
         </a>
         and
         <a class="local">
          'Pulmonary calcification associated with other lung diseases'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H157436315">
         <span class="h2">
          Treatment and prognosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is no established therapy for PAM. Systemic glucocorticoids, chelating agents, and whole lung bronchoalveolar lavage have not demonstrated benefit [
         <a href="#rid8">
          8,77,97
         </a>
         ]. The few cases that responded to glucocorticoid treatment were most likely related to effects on accompanying interstitial lung disease. Lung transplantation has been successful, and recurrence of PAM in the transplanted lungs has not been reported with follow up out to 15 years [
         <a href="#rid98">
          98-100
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4660.html" rel="external">
          "Lung transplantation: Disease-based choice of procedure"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Investigational therapy
         </strong>
         – Given the underlying abnormalities in phosphate transportation, bisphosphonates, which have an inhibitory effect on the precipitation of hydroxyapatite microcrystals, have been tried in small pediatric studies, resulting in improved long-term outcomes in some patients [
         <a href="#rid8">
          8,101,102
         </a>
         ]. In contrast, two case reports described a lack of radiologic improvement after 6 to 18 months of
         <a class="drug drug_general" data-topicid="8426" href="/z/d/drug information/8426.html" rel="external">
          etidronate
         </a>
         [
         <a href="#rid103">
          103,104
         </a>
         ]. Of note etidronate has largely been superseded by other bisphosphonates for the treatment of osteoporosis. In a single case report,
         <a class="drug drug_general" data-topicid="9939" href="/z/d/drug information/9939.html" rel="external">
          sodium thiosulfate
         </a>
         , a calcium-chelating and -solubilizing agent, failed to improve PAM [
         <a href="#rid105">
          105
         </a>
         ]. Given the indolent nature of PAM in many patients, additional studies of bisphosphonate therapy would be needed prior to more widespread use.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prognosis
         </strong>
         – Progression of PAM is generally slow, and it often takes decades before patients develop symptoms or reduced pulmonary function. However, long-term prognosis is poor with most patients eventually progressing to respiratory failure [
         <a href="#rid8">
          8,106
         </a>
         ]. A few case reports describe full or near term pregnancy in patients with PAM [
         <a href="#rid107">
          107,108
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2708513006">
         <span class="h1">
          PULMONARY OSSIFICATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pulmonary ossification can be localized or diffuse and may be idiopathic or caused by underlying cardiac, pulmonary, or systemic disorders. Some conditions associated with pulmonary ossification are also associated with metastatic or dystrophic calcification and may represent a continuum [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1403100180">
         <span class="h2">
          Nodular versus dendriform ossification
         </span>
         <span class="headingEndMark">
          —
         </span>
         Two histologic types of pulmonary ossification have been described, nodular and dendriform [
         <a href="#rid9">
          9-11,109
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Nodular
         </strong>
         – Nodular ossification is characterized by lamellar deposits of osteoid material within alveolar spaces visible on histopathology. Marrow elements are often absent. Nodular ossification is typically associated with underlying cardiac disorders such as mitral stenosis, chronic left ventricular failure, or idiopathic hypertrophic subaortic stenosis that result in chronic pulmonary venous congestion [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dendriform
         </strong>
         – Dendriform pulmonary ossification (DPO) is characterized by branching spicules of bone and marrow elements in the interstitium that may extend into the alveolar spaces (
         <a class="graphic graphic_picture graphicRef119127" href="/z/d/graphic/119127.html" rel="external">
          picture 1
         </a>
         ). It is the more common form of idiopathic pulmonary ossification and is also seen in patients with underlying lung fibrosis of the usual interstitial pneumonia pattern [
         <a href="#rid9">
          9,110
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H627516495">
         <span class="h2">
          Pathogenesis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pulmonary ossification usually occurs in the setting of preexisting tissue injury, though it may be idiopathic in nature. The process of ossification is complex and likely involves other physiologic alterations beyond dysregulation of serum calcium and phosphate, including angiogenesis, chronic venous congestion, and/or lung fibrosis [
         <a href="#rid1">
          1,25
         </a>
         ].
        </p>
        <p>
         Chronic injury or insult, such as chronic inflammation or increased shear stress as occurs in pulmonary fibrosis, may induce metaplastic transformation of fibroblasts to osteoblasts and has been suggested as a key element in the pathogenesis of ectopic ossification [
         <a href="#rid1">
          1,111,112
         </a>
         ]. Tissue hypoxia or anoxia from this injury results in an environment that may stimulate the process [
         <a href="#rid113">
          113
         </a>
         ]. Furthermore, elevated levels of intracellular calcium at sites of tissue and cellular injury can activate phospholipases and multiple other enzymes that promote cellular death and necrosis [
         <a href="#rid9">
          9
         </a>
         ]. Phospholipids that enter cells after injury degrade into fatty acids, and subsequent binding of calcium to these fatty acids promotes calcification at the sites of injury [
         <a href="#rid9">
          9,29
         </a>
         ]. Once a nidus of calcification forms, further calcium and phosphate crystallization can propagate [
         <a href="#rid1">
          1
         </a>
         ]. Shifts in pH from acidic to alkaline as injury progresses enhance the process of calcification [
         <a href="#rid114">
          114
         </a>
         ].
        </p>
        <p>
         The presence of collagen also enhances calcification and may explain why pulmonary ossification is often seen in patients with fibrotic lung disease. Several growth factors and cytokines implicated in pulmonary disease states may also contribute to the process of ossification. Of note, many of the growth factors listed above also participate in the process of pulmonary fibrosis and may therefore form a link between underlying pulmonary disorders, such as idiopathic pulmonary fibrosis (IPF), and subsequent pulmonary ossification [
         <a href="#rid115">
          115
         </a>
         ]. Cytokines involved in extracellular matrix formation and inflammation, such as transforming growth factor-beta (TGF-beta) are key in the pathogenesis of lung fibrosis. These same cytokines also promote differentiation of alveolar macrophages or fibroblasts into osteoclasts and osteoblasts in the presence of conducive microenvironmental conditions [
         <a href="#rid1">
          1,9
         </a>
         ]. In addition, bone morphogenetic protein-2, interleukin-4, and interleukin-1 may promote ectopic bone formation, bone remodeling, and osteoclast transformation [
         <a href="#rid1">
          1,9,10,116-118
         </a>
         ]. Alveolar hemorrhage may also predispose to ossification as hemosiderin deposits attract calcium salts [
         <a href="#rid9">
          9,119
         </a>
         ].
        </p>
        <p>
         Angiogenesis is required for normal bone formation and likely also plays a role in pathogenic calcification in the lungs. Osteogenic protein-1 (OP-1) is a bone growth factor that upregulates alkaline phosphatase activity and also enhances production of vascular endothelial growth factor (VEGF), a potent angiogenic growth factor [
         <a href="#rid120">
          120
         </a>
         ]. VEGF expression is similarly increased by parathyroid hormone, which is elevated in some cases of metastatic calcification. Prostaglandins E1 (PGE1) and PGE2 also stimulate both bone formation and VEGF production [
         <a href="#rid1">
          1,121,122
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1548881127">
         <span class="h2">
          Predisposing factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pulmonary ossification has been described in various settings, including idiopathic pulmonary hemosiderosis [
         <a href="#rid123">
          123
         </a>
         ], lung mucoepidermoid cancer [
         <a href="#rid124">
          124
         </a>
         ], osteogenesis imperfecta [
         <a href="#rid125">
          125
         </a>
         ], and rapid appearance and disappearance with diffuse alveolar hemorrhage [
         <a href="#rid126">
          126
         </a>
         ]. Familial cases have also been reported [
         <a href="#rid127">
          127-129
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fibrosing interstitial lung disease
         </strong>
         – Among 892 patients with fibrosing interstitial lung disease (ILD), there was a high prevalence (10 to 20 percent) of pulmonary ossification overall [
         <a href="#rid110">
          110
         </a>
         ]. A significantly higher prevalence of pulmonary ossification was noted among patients with IPF than with other ILDs, and a diagnosis of IPF was shown to be an independent risk factor for pulmonary ossification. The presence of DPO may be a useful marker for differentiating IPF from other ILDs, but more studies are needed [
         <a href="#rid130">
          130
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
         </strong>
         – Extensive DPO has been reported following SARS-CoV-2 pneumonia, most often in patients who have underlying ILD [
         <a href="#rid131">
          131
         </a>
         ]. Cicatricial organizing pneumonia that develops as a sequelae COVID-19 pneumonia or ARDS may also predispose to the development of DPO [
         <a href="#rid132">
          132
         </a>
         ]. In one case, residual SARS-CoV-2 viral load was detected in explanted lung tissue, suggesting a link between incomplete viral clearance and chronic pulmonary disease [
         <a href="#rid133">
          133
         </a>
         ]. While it remains unclear why fibroproliferation (as in the case of fibrosing interstitial lung disease or severe ARDS) predisposes to DPO, it is interesting to note that the signaling pathways of bone morphogenic protein (BMP) and TGF-beta are highly interconnected, and crosstalk between these pathways in the setting of inflammation may promote bone formation [
         <a href="#rid134">
          134
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chronic acid aspiration
         </strong>
         – In a retrospective study of 52 patients with radiographic evidence of DPO, defined as micronodules in the peripheral interstitium, contiguous clusters, and nodules in a branching pattern but without usual interstitial pneumonitis or focal lung disease, 75 percent of the patients had gastroesophageal reflux, obstructive sleep apnea, or a chronic neurologic disorder, raising the possibility that DPO without lung fibrosis may be due to chronic aspiration [
         <a href="#rid135">
          135,136
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H839505429">
         <span class="h2">
          Clinical presentation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pulmonary ossification is rare (estimated United States prevalence of 0.5 percent, and incidence of 0.28 cases per year) and typically presents in older men, though pulmonary ossification has been reported in women and younger adults [
         <a href="#rid11">
          11,137,138
         </a>
         ]. Many cases are found incidentally during imaging performed for another reason; some cases are diagnosed at autopsy [
         <a href="#rid10">
          10
         </a>
         ]. Most patients are asymptomatic or have symptoms related to the underlying lung disease.
        </p>
        <p class="headingAnchor" id="H3731562508">
         <span class="h2">
          Diagnostic evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of DPO is based on the appearance of the lungs on high resolution computed tomography (HRCT) and the clinical setting [
         <a href="#rid9">
          9
         </a>
         ]. Radiographic recognition of pulmonary ossification is important as it may avoid the risks associated with lung biopsy.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Laboratory testing
         </strong>
         – As with dystrophic calcification, serum levels of calcium and phosphate are generally normal.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary function tests
         </strong>
         – When the disease is severe, restrictive lung disease and reduced diffusion capacity are seen on lung function tests. However, when pulmonary ossification is secondary to another underlying lung disease, such as IPF, the respiratory symptoms and dysfunction are often due to the primary disorder [
         <a href="#rid1">
          1,9,139
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Imaging
         </strong>
         – Chest radiographs demonstrate coarse reticular opacities in the lower lung zones [
         <a href="#rid1">
          1
         </a>
         ]. HRCT demonstrates linear 1 to 5 mm calcific densities, typically in the lung periphery (
         <a class="graphic graphic_picture graphicRef119126" href="/z/d/graphic/119126.html" rel="external">
          picture 2
         </a>
         ); punctate, miliary, or nodular calcifications are also seen [
         <a href="#rid1">
          1,9,38,119,135,138
         </a>
         ]. Confirmation is provided by measurements showing the density of lesions is consistent with bone.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3483327833">
         <span class="h2">
          Treatment and complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         Treatment options for pulmonary ossification are relatively limited. Oral glucocorticoids, calcium-binding drugs, and low-calcium diets have no demonstrated benefit, though systematic studies have not been conducted [
         <a href="#rid1">
          1,9
         </a>
         ]. Similarly, bisphosphonates appear unlikely to be of benefit but have not been fully studied. As with most forms of pulmonary calcification, treatment in symptomatic patients should be aimed at any underlying pulmonary processes that are amenable to intervention.
        </p>
        <p>
         Several cases of (spontaneous) pneumothorax have been reported in patients with DPO; one plausible pathogenic mechanism is that subpleural calcified (spicules) impaled the pleural space, leading to the air leak [
         <a href="#rid10">
          10,127,128,140-143
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1316380637">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definitions and classification
         </strong>
         – Pulmonary calcification and ossification are relatively rare diseases (
         <a class="graphic graphic_table graphicRef119125" href="/z/d/graphic/119125.html" rel="external">
          table 1
         </a>
         ). Metastatic and dystrophic calcification are defined as deposition of calcium salts in normal and abnormal tissues, respectively. Pulmonary ossification refers to bone tissue formation (calcification in a collagen matrix) in the lungs, with or without marrow elements. (See
         <a class="local">
          'Definitions and classification'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Metastatic pulmonary calcification
         </strong>
         – Metastatic pulmonary calcification (MPC) is defined by calcium salt deposition in normal tissues. MPC can result from benign or malignant processes, though the most common cause is end-stage kidney disease (ESKD) being treated with chronic hemodialysis. (See
         <a class="local">
          'Metastatic pulmonary calcification'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         On high-resolution computed tomography (HRCT), MPC can present with any of three patterns alone or in combination: multiple calcified nodules in a diffuse or localized distribution, diffuse or patchy areas of ground glass opacification, and/or dense area(s) of consolidation mimicking a lobar pneumonia. Scanning with
         <sup>
          99m
         </sup>
         technetium-methylene diphosphate (
         <sup>
          99m
         </sup>
         Tc-MDP) can be helpful when the HRCT findings are not sufficiently diagnostic. (See
         <a class="local">
          'Imaging'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients with MPC, conditions that elevate the calcium-phosphate product should be corrected to prevent further calcification. (See
         <a class="local">
          'Treatment'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dystrophic calcification
         </strong>
         – Dystrophic calcification refers to deposition of calcium salts in abnormal tissue, such as occurs in infection (mycobacterial, fungal, or viral), noninfectious granulomatous diseases, pneumoconioses, amyloidosis (
         <a class="graphic graphic_diagnosticimage graphicRef87611" href="/z/d/graphic/87611.html" rel="external">
          image 3
         </a>
         ), and various fibrotic lung diseases. (See
         <a class="local">
          'Dystrophic calcification'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary alveolar microlithiasis
         </strong>
         – Pulmonary alveolar microlithiasis (PAM) is a unique form of pulmonary calcification due to a genetic defect in a lung-specific
         <a class="drug drug_general" data-topicid="10269" href="/z/d/drug information/10269.html" rel="external">
          sodium phosphate
         </a>
         cotransporter (
         <em>
          SLC34A2
         </em>
         ). (See
         <a class="local">
          'Pulmonary alveolar microlithiasis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In PAM, the chest radiograph shows a "sandstorm" appearance with diffuse scattered calcific micronodules and the HRCT shows micronodular calcifications primarily along bronchovascular bundles, subpleural and perilobular regions. The diagnosis of PAM can usually be made based on the HRCT appearance, and lung biopsy is rarely needed, particularly in a family with a known affected member. (See
         <a class="local">
          'Evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pulmonary ossification
         </strong>
         – Pulmonary ossification refers to the formation of mature bone tissue within the lungs. Ossification can be idiopathic or secondary to a primary pulmonary, cardiac, or metabolic disorder. HRCT demonstrates linear 1 to 5 mm calcific densities, typically in the lung periphery. (See
         <a class="local">
          'Pulmonary ossification'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         While pulmonary ossification is often asymptomatic, it may be a marker of disease severity, as in the case of pulmonary fibrosis. Treatment for symptomatic patients is usually aimed at treating the underlying pulmonary disease. (See
         <a class="local">
          'Treatment and complications'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Chan ED, Morales DV, Welsh CH, et al. Calcium deposition with or without bone formation in the lung. Am J Respir Crit Care Med 2002; 165:1654.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belém LC, Zanetti G, Souza AS Jr, et al. Metastatic pulmonary calcification: state-of-the-art review focused on imaging findings. Respir Med 2014; 108:668.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brown K, Mund DF, Aberle DR, et al. Intrathoracic calcifications: radiographic features and differential diagnoses. Radiographics 1994; 14:1247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           MULLIGAN RM. Metastatic calcification. Arch Pathol (Chic) 1947; 43:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Conger JD, Hammond WS, Alfrey AC, et al. Pulmonary calcification in chronic dialysis patients. Clinical and pathologic studies. Ann Intern Med 1975; 83:330.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Justrabo E, Genin R, Rifle G. Pulmonary metastatic calcification with respiratory insufficiency in patients on maintenance haemodialysis. Thorax 1979; 34:384.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McLachlan MS, Wallace M, Seneviratne C. Pulmonary calcification in renal failure. Report of three cases. Br J Radiol 1968; 41:99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Castellana G, Castellana G, Gentile M, et al. Pulmonary alveolar microlithiasis: review of the 1022 cases reported worldwide. Eur Respir Rev 2015; 24:607.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peros-Golubicić T, Tekavec-Trkanjec J. Diffuse pulmonary ossification: an unusual interstitial lung disease. Curr Opin Pulm Med 2008; 14:488.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Konoglou M, Zarogoulidis P, Baliaka A, et al. Lung ossification: an orphan disease. J Thorac Dis 2013; 5:101.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lara JF, Catroppo JF, Kim DU, da Costa D. Dendriform pulmonary ossification, a form of diffuse pulmonary ossification: report of a 26-year autopsy experience. Arch Pathol Lab Med 2005; 129:348.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jamjoom L, Meziane M, Renapurkar RD. Dendriform pulmonary ossification: Report of two cases. Indian J Radiol Imaging 2013; 23:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kuzela DC, Huffer WE, Conger JD, et al. Soft tissue calcification in chronic dialysis patients. Am J Pathol 1977; 86:403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaltreider HB, Baum GL, Bogaty G, et al. So-called "metastatic" calcification of the lung. Am J Med 1969; 46:188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cohen AM, Maxon HR, Goldsmith RE, et al. Metastatic pulmonary calcification in primary hyperparathyroidism. Arch Intern Med 1977; 137:520.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Libson E, Wechsler RJ, Steiner RM. Pulmonary calcinosis following orthotopic liver transplantation. J Thorac Imaging 1993; 8:305.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           WILSON CW, WINGFIELD WL, TOONE EC Jr. Vitamin D poisoning with metastatic calcification; report of a case and review of the mechanism of intoxication. Am J Med 1953; 14:116.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Neff M, Yalcin S, Gupta S, Berger H. Extensive metastatic calcification of the lung in an azotemic patient. Am J Med 1974; 56:103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davies MR, Hruska KA. Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int 2001; 60:472.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bendayan D, Barziv Y, Kramer MR. Pulmonary calcifications: a review. Respir Med 2000; 94:190.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Breitz HB, Sirotta PS, Nelp WB, et al. Progressive pulmonary calcification complicating successful renal transplantation. Am Rev Respir Dis 1987; 136:1480.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mine Y, Ito N, Tagawa M, et al. [Metastatic calcification associated with malignancy]. Gan No Rinsho 1988; 34:2044.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allegra L. Experimental pulmonary calcification. Exp Med Surg 1965; 23:227.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yasuo M, Tanabe T, Komatsu Y, et al. Progressive pulmonary calcification after successful renal transplantation. Intern Med 2008; 47:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brodeur FJ Jr, Kazerooni EA. Metastatic pulmonary calcification mimicking air-space disease. Technetium-99m-MDP SPECT imaging. Chest 1994; 106:620.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duthie JS, Solanki HP, Krishnamurthy M, Chertow BS. Milk-alkali syndrome with metastatic calcification. Am J Med 1995; 99:102.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bloodworth J, Tomashefski JF Jr. Localised pulmonary metastatic calcification associated with pulmonary artery obstruction. Thorax 1992; 47:174.
          </a>
         </li>
         <li class="breakAll">
          Moss DW, Henderson AR. Clinical enzymology. In: Tietz Textbook of Clinical Chemistry, Burtis CA, Ashwood ER (Eds), W.B. Saunders, Philadelphia 1999. p.617.
         </li>
         <li class="breakAll">
          York JL. Enzymes: Classification, kinetics, and control. In: Textbook of Biochemistry with Clinical Correlations, Devlin TM (Ed), Wiley-Liss, New York 2002. p.413.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mootz JR, Sagel SS, Roberts TH. Roentgenographic manifestations of pulmonary calcifications. A rare cause of respiratory failure in chronic renal disease. Radiology 1973; 107:55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khafif RA, DeLima C, Silverberg A, Frankel R. Calciphylaxis and systemic calcinosis. Collective review. Arch Intern Med 1990; 150:956.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davidson RC, Pendros JP. Calcium related cardio-respiratory death in chronic hemodialysis. Trans Am Soc Artif Intern Organs 1967; 13:36.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greenberg S, Suster B. Metastatic pulmonary calcification: appearance on high resolution CT. J Comput Assist Tomogr 1994; 18:497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hartman TE, Müller NL, Primack SL, et al. Metastatic pulmonary calcification in patients with hypercalcemia: findings on chest radiographs and CT scans. AJR Am J Roentgenol 1994; 162:799.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Johkoh T, Ikezoe J, Nagareda T, et al. Metastatic pulmonary calcification: early detection by high-resolution CT. J Comput Assist Tomogr 1993; 17:471.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Belém LC, Souza CA, Souza AS Jr, et al. Metastatic pulmonary calcification: high-resolution computed tomography findings in 23 cases. Radiol Bras 2017; 50:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Low SY, Chau YP, Cheah FK. A 52-year-old man presenting with chronic cough and bilateral ground-glass opacities on CT of the thorax. Chest 2007; 132:1401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gevenois PA, Abehsera M, Knoop C, et al. Disseminated pulmonary ossification in end-stage pulmonary fibrosis: CT demonstration. AJR Am J Roentgenol 1994; 162:1303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lingam RK, Teh J, Sharma A, Friedman E. Case report. Metastatic pulmonary calcification in renal failure: a new HRCT pattern. Br J Radiol 2002; 75:74.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aso Y, Sato A, Tayama K, et al. Parathyroid carcinoma with metastatic calcification identified by technetium-99m methylene diphosphonate scintigraphy. Intern Med 1996; 35:392.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Grames GM, Sauser DD, Jansen C, et al. Radionuclide detection of diffuse interstitial pulmonary calcification. JAMA 1974; 230:992.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenthal DI, Chandler HL, Azizi F, Schneider PB. Uptake of bone imaging agents by diffuse pulmonary metastatic calcification. AJR Am J Roentgenol 1977; 129:871.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coolens JL, Devos P, De Roo M. Diffuse pulmonary uptake of 99mTc bone-imaging agents: case report and survey. Eur J Nucl Med 1985; 11:36.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robinson RR. Isolated proteinuria in asymptomatic patients. Kidney Int 1980; 18:395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thurley PD, Duerden R, Roe S, Pointon K. Case report: Rapidly progressive metastatic pulmonary calcification: evolution of changes on CT. Br J Radiol 2009; 82:e155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fulladosa X, González MT, Cruzado JM, et al. Metastatic pulmonary calcifications in severe secondary hyperparathyroidism: evolution after renal transplantation. Transplant Proc 1995; 27:2272.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murris-Espin M, Lacassagne L, Didier A, et al. Metastatic pulmonary calcification after renal transplantation. Eur Respir J 1997; 10:1925.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marchiori E, Müller NL, Souza AS Jr, et al. Unusual manifestations of metastatic pulmonary calcification: high-resolution CT and pathological findings. J Thorac Imaging 2005; 20:66.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bell NH, Shary J, Shaw S, Turner RT. Hypercalcemia associated with increased circulating 1,25 dihydroxyvitamin D in a patient with pulmonary tuberculosis. Calcif Tissue Int 1985; 37:588.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kerr DN. Hypercalcemia and metastatic calcification. Cardiovasc Res 1997; 36:293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stewart VL, Herling P, Dalinka MK. Calcification in soft tissues. JAMA 1983; 250:78.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gurney JW, Conces DJ. Pulmonary histoplasmosis. Radiology 1996; 199:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Palayew MJ, Frank H. Benign progressive multinodular pulmonary histoplasmosis. A radiological and clinical entity. Radiology 1974; 111:311.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alshabani K, Ghosh S, Arrossi AV, Mehta AC. Broncholithiasis: A Review. Chest 2019; 156:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blumenfeld W, Basgoz N, Owen WF Jr, Schmidt DM. Granulomatous pulmonary lesions in patients with the acquired immunodeficiency syndrome (AIDS) and Pneumocystis carinii infection. Ann Intern Med 1988; 109:505.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feuerstein IM, Francis P, Raffeld M, Pluda J. Widespread visceral calcifications in disseminated Pneumocystis carinii infection: CT characteristics. J Comput Assist Tomogr 1990; 14:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Travis WD, Pittaluga S, Lipschik GY, et al. Atypical pathologic manifestations of Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Review of 123 lung biopsies from 76 patients with emphasis on cysts, vascular invasion, vasculitis, and granulomas. Am J Surg Pathol 1990; 14:615.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           KATZ S, STANTON J, McCORMICK G. Miliary calcification of the lungs after treated miliary tuberculosis. N Engl J Med 1955; 253:135.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roussos A, Lagogianni I, Gonis A, et al. Hypercalcaemia in Greek patients with tuberculosis before the initiation of anti-tuberculosis treatment. Respir Med 2001; 95:187.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones EL, Cameron AH. Pulmonary calcification in viral pneumonia. J Clin Pathol 1969; 22:361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Knyvett AF. The pulmonary lesions of chickenpox. Q J Med 1966; 35:313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foster DR. Case report: pulmonary calcification in smallpox handler's lung. Br J Radiol 1994; 67:599.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ross PJ, Seaton A, Foreman HM, Morris Evans WH. Pulmonary calcification following smallpox handler's lung. Thorax 1974; 29:659.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mannhardt W, Schumacher R. Progressive calcifications of lung and liver in neonatal herpes simplex virus infection. Pediatr Radiol 1991; 21:236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen SZ. [An analysis of radiologic signs of typical pulmonary calcification in 8 cases of paragonimiasis]. Zhonghua Fang She Xue Za Zhi 1984; 18:128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aydin Y, Gursan N, Turkyilmaz A, Eroglu A. Mediastinal calcified hydatid cyst. Ann Thorac Surg 2011; 92:e85.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cappello E, Cacopardo B, Caltabiano E, et al. Epidemiology and clinical features of cystic hydatidosis in Western Sicily: a ten-year review. World J Gastroenterol 2013; 19:9351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sayek I, Tirnaksiz MB, Dogan R. Cystic hydatid disease: current trends in diagnosis and management. Surg Today 2004; 34:987.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levine E. Abdominal visceral calcification in secondary amyloidosis: CT findings. Abdom Imaging 1994; 19:554.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kim HY, Im JG, Song KS, et al. Localized amyloidosis of the respiratory system: CT features. J Comput Assist Tomogr 1999; 23:627.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laden SA, Cohen ML, Harley RA. Nodular pulmonary amyloidosis with extrapulmonary involvement. Hum Pathol 1984; 15:594.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weinstein DS. Pulmonary sarcoidosis: calcified micronodular pattern simulating pulmonary alveolar microlithiasis. J Thorac Imaging 1999; 14:218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ferreira Francisco FA, Pereira e Silva JL, Hochhegger B, et al. Pulmonary alveolar microlithiasis. State-of-the-art review. Respir Med 2013; 107:1.
          </a>
         </li>
         <li class="breakAll">
          Online Mendelian Inheritance in Man (OMIM). Pulmonary alveolar microlithiasis. https://www.omim.org/entry/265100 (Accessed on June 26, 2018).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Corut A, Senyigit A, Ugur SA, et al. Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet 2006; 79:650.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huqun, Izumi S, Miyazawa H, et al. Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis. Am J Respir Crit Care Med 2007; 175:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yin X, Wang H, Wu D, et al. SLC34A2 Gene mutation of pulmonary alveolar microlithiasis: report of four cases and review of literatures. Respir Med 2013; 107:217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang XD, Gao JM, Luo JM, Zhao Y. Pulmonary alveolar microlithiasis: A case report and review of the literature. Exp Ther Med 2018; 15:831.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bendstrup E, Jönsson ÅLM. Pulmonary alveolar microlithiasis: no longer in the stone age. ERJ Open Res 2020; 6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jönsson ÅLM, Hilberg O, Simonsen U, et al. New insights in the genetic variant spectrum of SLC34A2 in pulmonary alveolar microlithiasis; a systematic review. Orphanet J Rare Dis 2023; 18:130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poelma DL, Ju MR, Bakker SC, et al. A common pathway for the uptake of surfactant lipids by alveolar cells. Am J Respir Cell Mol Biol 2004; 30:751.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khaladkar SM, Kondapavuluri SK, Kamal A, et al. Pulmonary Alveolar Microlithiasis - Clinico-Radiological dissociation - A case report with Radiological review. J Radiol Case Rep 2016; 10:14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jönsson ÅLM, Bendstrup E, Mogensen S, et al. Eight novel variants in the SLC34A2 gene in pulmonary alveolar microlithiasis. Eur Respir J 2020; 55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mariotta S, Guidi L, Papale M, et al. Pulmonary alveolar microlithiasis: review of Italian reports. Eur J Epidemiol 1997; 13:587.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mariotta S, Ricci A, Papale M, et al. Pulmonary alveolar microlithiasis: report on 576 cases published in the literature. Sarcoidosis Vasc Diffuse Lung Dis 2004; 21:173.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stamatopoulos A, Patrini D, Mitsos S, et al. An unusual late onset of pulmonary alveolar microlithiasis: A case report and literature review. Respir Med Case Rep 2017; 22:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sigur E, Roditis L, Labouret G, et al. Pulmonary Alveolar Microlithiasis in Children Less than 5 Years of Age. J Pediatr 2020; 217:158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cluzel P, Grenier P, Bernadac P, et al. Pulmonary alveolar microlithiasis: CT findings. J Comput Assist Tomogr 1991; 15:938.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saito A, McCormack FX. Pulmonary Alveolar Microlithiasis. Clin Chest Med 2016; 37:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dodge DL, Cherian SV, Ali YD, et al. A 35-Year-Old Woman With Progressive Dyspnea and Cough. Chest 2020; 158:e103.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Devine OP, Harborne AC. Pneumothorax secondary to pulmonary alveolar microlithiasis. Clin Case Rep 2018; 6:764.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen CW, Wu FZ. Progressive Sandstorm Lung in Pulmonary Alveolar Microlithiasis. Ann Thorac Surg 2019; 107:e55.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ufuk F. Pulmonary Alveolar Microlithiasis. Radiology 2021; 298:567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Delic JA, Fuhrman CR, Trejo Bittar HE. Pulmonary Alveolar Microlithiasis: AIRP Best Cases in Radiologic-Pathologic Correlation. Radiographics 2016; 36:1334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Şen AE, Şahin Ö, Aydın Z, et al. A Rare Case of Pulmonary Alveolar Microlithiasis with Diffuse Lung Uptake on Bone Scintigraphy. Mol Imaging Radionucl Ther 2022; 31:151.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chatterji R, Gaude GS, Patil PV. Pulmonary alveolar microlithiasis: diagnosed by sputum examination and transbronchial biopsy. Indian J Chest Dis Allied Sci 1997; 39:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Palombini BC, da Silva Porto N, Wallau CU, Camargo JJ. Bronchopulmonary lavage in alveolar microlithiasis. Chest 1981; 80:242.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shigemura N, Bermudez C, Hattler BG, et al. Lung transplantation for pulmonary alveolar microlithiasis. J Thorac Cardiovasc Surg 2010; 139:e50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Samano MN, Waisberg DR, Canzian M, et al. Lung transplantation for pulmonary alveolar microlithiasis: a case report. Clinics (Sao Paulo) 2010; 65:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klikovits T, Slama A, Hoetzenecker K, et al. A rare indication for lung transplantation - pulmonary alveolar microlithiasis: institutional experience of five consecutive cases. Clin Transplant 2016; 30:429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ozcelik U, Yalcin E, Ariyurek M, et al. Long-term results of disodium etidronate treatment in pulmonary alveolar microlithiasis. Pediatr Pulmonol 2010; 45:514.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Azim S, Azim W, Hayat F, Shafi H. Treatment of pulmonary alveolar microlithiasis with allendronate sodium. Biomedica 2004; 20:32.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mariotta S, Guidi L, Mattia P, et al. Pulmonary microlithiasis. Report of two cases. Respiration 1997; 64:165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jankovic S, Pavlov N, Ivkosic A, et al. Pulmonary alveolar microlithiasis in childhood: clinical and radiological follow-up. Pediatr Pulmonol 2002; 34:384.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taillé C, Debray MP, Danel C, et al. Calcium-solubilizing sodium thiosulfate failed to improve pulmonary alveolar microlithiasis: Evaluation of calcium content with CT scan. Respir Med Res 2019; 75:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jönsson ÅL, Simonsen U, Hilberg O, Bendstrup E. Pulmonary alveolar microlithiasis: two case reports and review of the literature. Eur Respir Rev 2012; 21:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rodríguez F, Ferrer J, Briozzo L, Pons J. Pulmonary alveolar microlithiasis and pregnancy. J Matern Fetal Neonatal Med 2006; 19:239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Souza Filho JO, Silveira CM, Cunha AB, et al. Pregnancy in a patient with severe pulmonary alveolar microlithiasis. J Bras Pneumol 2008; 34:885.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernández Crisosto CA, Quercia Arias O, Bustamante N, et al. [Diffuse pulmonary ossification associated with idiopathic pulmonary fibrosis]. Arch Bronconeumol 2004; 40:595.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Egashira R, Jacob J, Kokosi MA, et al. Diffuse Pulmonary Ossification in Fibrosing Interstitial Lung Diseases: Prevalence and Associations. Radiology 2017; 284:255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Popelka CG, Kleinerman J. Diffuse pulmonary ossification. Arch Intern Med 1977; 137:523.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reddi AH, Huggins CB. Cyclic electrochemical inactivation and restoration of competence of bone matrix to transform fibroblasts. Proc Natl Acad Sci U S A 1974; 71:1648.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jaderborg JM, Dunton RF. Rare clinical diagnosis of dendriform pulmonary ossification. Ann Thorac Surg 2001; 71:2009.
          </a>
         </li>
         <li class="breakAll">
          Kumar V, Abbas AK, Aster JC. Robbins and Cotran Pathologic Basis of Disease, Elsevier/Saunders, Philadelphia 2015.
         </li>
         <li class="breakAll">
          Chan ED, Worthen GS, Augustin A, et al. Inflammation in the pathogenesis of interstitial lung disease. In: Interstitial Lung Disease, 3rd ed, Schwarz MI, King TE (Eds), BC Decker, Inc, Hamilton, Ontario 1998. p.135.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mahy PR, Urist MR. Experimental heterotopic bone formation induced by bone morphogenetic protein and recombinant human interleukin-1B. Clin Orthop Relat Res 1988; :236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maiti SK, Singh GR. Bone morphogenetic proteins--novel regulators of bone formation. Indian J Exp Biol 1998; 36:237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsuji T, Nakamura S, Komuro I, et al. A living case of pulmonary ossification associated with osteoclast formation from alveolar macrophage in the presence of T-cell cytokines. Intern Med 2003; 42:834.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marchiori E, Souza AS Jr, Franquet T, Müller NL. Diffuse high-attenuation pulmonary abnormalities: a pattern-oriented diagnostic approach on high-resolution CT. AJR Am J Roentgenol 2005; 184:273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yeh LC, Lee JC. Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells. Mol Cell Endocrinol 1999; 153:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harada S, Nagy JA, Sullivan KA, et al. Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest 1994; 93:2490.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang DS, Yamazaki K, Nohtomi K, et al. Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells. J Bone Miner Res 1996; 11:472.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barrera AM, Vargas L. [Idiopathic pulmonary hemosiderosis with dendriform pulmonary ossification]. Biomedica 2016; 36:504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Triki M, Kallel R, Hentati A, et al. Dendriform pulmonary ossification in a patient with mucoepidermoid carcinoma. Asian Cardiovasc Thorac Ann 2016; 24:604.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morikawa M, Fukuda Y, Terasaki Y, et al. Osteogenesis Imperfecta Associated with Dendriform Pulmonary Ossification. Am J Respir Crit Care Med 2016; 193:460.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yamagishi T, Fujimoto N, Miyamoto Y, et al. The Rapid Appearance and Disappearance of Dendriform Pulmonary Ossification after Diffuse Alveolar Hemorrhage. Am J Respir Crit Care Med 2016; 193:333.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Azuma A, Miyamoto H, Enomoto T, et al. Familial clustering of dendriform pulmonary ossification. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20:152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsai AP, English JC, Murphy D, Sin DD. Recurrent pneumothorax related to diffuse dendriform pulmonary ossification in genetically predisposed individual. Respirol Case Rep 2017; 5:e00211.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kinoshita Y, Mizuguchi I, Hidaka K, et al. Familial diffuse pulmonary ossification: A possible genetic disorder. Respir Investig 2017; 55:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Palermo M, Tiralongo F, Distefano G, et al. Quantitative Evaluation of Fibrosis in IPF Patients: Meaning of Diffuse Pulmonary Ossification. Diagnostics (Basel) 2021; 11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           García Moreno B, Buitrago Weiland G, Sánchez Alegre ML, Vanegas Rodríguez JE. Accelerated Pulmonary Ossification as a Sequela of SARS-CoV-2 Pneumonia. Radiol Cardiothorac Imaging 2021; 3:e200598.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Torres PPTES, Rabahi MF, Marchiori E. Dendriform pulmonary ossification in coronavirus disease 2019 pneumonia. Rev Soc Bras Med Trop 2022; 55:e0621.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haslbauer JD, Bratic-Hench I, Cima K, et al. Interstitial Pulmonary Fibrosis and Extensive Dendriform Ossification with Persistent Viral Load: A Rare Presentation of Post-COVID-19 Condition in Need of Lung Transplantation. Pathobiology 2023; 90:138.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rahman MS, Akhtar N, Jamil HM, et al. TGF-β/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation. Bone Res 2015; 3:15005.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gruden JF, Green DB, Legasto AC, et al. Dendriform Pulmonary Ossification in the Absence of Usual Interstitial Pneumonia: CT Features and Possible Association With Recurrent Acid Aspiration. AJR Am J Roentgenol 2017; 209:1209.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fernández-Bussy S, Labarca G, Pires Y, et al. Dendriform pulmonary ossification. Respir Care 2015; 60:e64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bisceglia M, Chiaramonte A, Panniello G, et al. Selected case from the Arkadi M. Rywlin international pathology slide series: diffuse dendriform pulmonary ossification: report of 2 cases with review of the literature. Adv Anat Pathol 2015; 22:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tzilas V, Kyriazis P, Tzouvelekis A, et al. A 63-Year-Old Woman With Pulmonary Micronodules and Chronic Cough. Chest 2019; 156:e47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Matsuo H, Handa T, Tsuchiya M, et al. Progressive Restrictive Ventilatory Impairment in Idiopathic Diffuse Pulmonary Ossification. Intern Med 2018; 57:1631.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abe J, Oura H, Niikawa H, et al. Dendriform pulmonary ossification: unusual cause of spontaneous pneumothorax. Thorax 2014; 69:97.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kato T, Ishikawa K, Kadoya M, et al. Spontaneous pneumothorax in a patient with dendriform pulmonary ossification: report of a case. Surg Today 2012; 42:903.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ekholdt PF, Oppedal BR, Arva P. Diffuse pulmonary ossification and spontaneous pneumothorax in a pilot: a case report. Aviat Space Environ Med 1986; 57:696.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ikeda Y, Yamashita H, Tamura T. Diffuse pulmonary ossification and recurrent spontaneous pneumothorax in a patient with bronchial asthma. Respir Med 1998; 92:887.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 117030 Version 17.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12070068" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Calcium deposition with or without bone formation in the lung.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24529738" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Metastatic pulmonary calcification: state-of-the-art review focused on imaging findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7855339" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Intrathoracic calcifications: radiographic features and differential diagnoses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20288665" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Metastatic calcification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1190631" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Pulmonary calcification in chronic dialysis patients. Clinical and pathologic studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/483215" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Pulmonary metastatic calcification with respiratory insufficiency in patients on maintenance haemodialysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5635915" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Pulmonary calcification in renal failure. Report of three cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26621975" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Pulmonary alveolar microlithiasis: review of the 1022 cases reported worldwide.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18664981" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Diffuse pulmonary ossification: an unusual interstitial lung disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23372958" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Lung ossification: an orphan disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15737029" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Dendriform pulmonary ossification, a form of diffuse pulmonary ossification: report of a 26-year autopsy experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23986613" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Dendriform pulmonary ossification: Report of two cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/836675" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Soft tissue calcification in chronic dialysis patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5775001" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : So-called "metastatic" calcification of the lung.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/849084" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Metastatic pulmonary calcification in primary hyperparathyroidism.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8246329" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Pulmonary calcinosis following orthotopic liver transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/13016591" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Vitamin D poisoning with metastatic calcification; report of a case and review of the mechanism of intoxication.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4129266" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Extensive metastatic calcification of the lung in an azotemic patient.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11473629" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Pathophysiological mechanisms of vascular calcification in end-stage renal disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10783928" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Pulmonary calcifications: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3318601" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Progressive pulmonary calcification complicating successful renal transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3230635" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : [Metastatic calcification associated with malignancy].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5843913" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Experimental pulmonary calcification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18239325" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Progressive pulmonary calcification after successful renal transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7774354" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Metastatic pulmonary calcification mimicking air-space disease. Technetium-99m-MDP SPECT imaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7598127" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Milk-alkali syndrome with metastatic calcification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1519194" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Localised pulmonary metastatic calcification associated with pulmonary artery obstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1519194" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Localised pulmonary metastatic calcification associated with pulmonary artery obstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1519194" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Localised pulmonary metastatic calcification associated with pulmonary artery obstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4689443" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Roentgenographic manifestations of pulmonary calcifications. A rare cause of respiratory failure in chronic renal disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2184792" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Calciphylaxis and systemic calcinosis. Collective review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Calcium related cardio-respiratory death in chronic hemodialysis
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8188924" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Metastatic pulmonary calcification: appearance on high resolution CT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8140993" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Metastatic pulmonary calcification in patients with hypercalcemia: findings on chest radiographs and CT scans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8491913" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Metastatic pulmonary calcification: early detection by high-resolution CT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28894330" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Metastatic pulmonary calcification: high-resolution computed tomography findings in 23 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17934129" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : A 52-year-old man presenting with chronic cough and bilateral ground-glass opacities on CT of the thorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8191986" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Disseminated pulmonary ossification in end-stage pulmonary fibrosis: CT demonstration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11806963" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Case report. Metastatic pulmonary calcification in renal failure: a new HRCT pattern.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8797054" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Parathyroid carcinoma with metastatic calcification identified by technetium-99m methylene diphosphonate scintigraphy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4479544" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Radionuclide detection of diffuse interstitial pulmonary calcification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/410253" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Uptake of bone imaging agents by diffuse pulmonary metastatic calcification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3899657" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Diffuse pulmonary uptake of 99mTc bone-imaging agents: case report and survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7463951" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Isolated proteinuria in asymptomatic patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19592398" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Case report: Rapidly progressive metastatic pulmonary calcification: evolution of changes on CT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7652803" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Metastatic pulmonary calcifications in severe secondary hyperparathyroidism: evolution after renal transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9272941" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Metastatic pulmonary calcification after renal transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15818203" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Unusual manifestations of metastatic pulmonary calcification: high-resolution CT and pathological findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3937578" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Hypercalcemia associated with increased circulating 1,25 dihydroxyvitamin D in a patient with pulmonary tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9534848" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Hypercalcemia and metastatic calcification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6854888" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Calcification in soft tissues.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8668768" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Pulmonary histoplasmosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4818969" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Benign progressive multinodular pulmonary histoplasmosis. A radiological and clinical entity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31173766" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Broncholithiasis: A Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3261957" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Granulomatous pulmonary lesions in patients with the acquired immunodeficiency syndrome (AIDS) and Pneumocystis carinii infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2298984" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Widespread visceral calcifications in disseminated Pneumocystis carinii infection: CT characteristics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2192568" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Atypical pathologic manifestations of Pneumocystis carinii pneumonia in the acquired immune deficiency syndrome. Review of 123 lung biopsies from 76 patients with emphasis on cysts, vascular invasion, vasculitis, and granulomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14394343" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Miliary calcification of the lungs after treated miliary tuberculosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11266235" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Hypercalcaemia in Greek patients with tuberculosis before the initiation of anti-tuberculosis treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5784985" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Pulmonary calcification in viral pneumonia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5956441" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : The pulmonary lesions of chickenpox.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8032817" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Case report: pulmonary calcification in smallpox handler's lung.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4375310" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Pulmonary calcification following smallpox handler's lung.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2047171" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Progressive calcifications of lung and liver in neonatal herpes simplex virus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6240383" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : [An analysis of radiologic signs of typical pulmonary calcification in 8 cases of paragonimiasis].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21958837" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Mediastinal calcified hydatid cyst.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24409062" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Epidemiology and clinical features of cystic hydatidosis in Western Sicily: a ten-year review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15580379" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Cystic hydatid disease: current trends in diagnosis and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7820033" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Abdominal visceral calcification in secondary amyloidosis: CT findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10433298" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Localized amyloidosis of the respiratory system: CT features.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6724579" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Nodular pulmonary amyloidosis with extrapulmonary involvement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10404510" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Pulmonary sarcoidosis: calcified micronodular pattern simulating pulmonary alveolar microlithiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23183116" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Pulmonary alveolar microlithiasis. State-of-the-art review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23183116" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Pulmonary alveolar microlithiasis. State-of-the-art review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16960801" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17095743" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Mutations in the SLC34A2 gene are associated with pulmonary alveolar microlithiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23164546" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : SLC34A2 Gene mutation of pulmonary alveolar microlithiasis: report of four cases and review of literatures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29434686" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Pulmonary alveolar microlithiasis: A case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32964001" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Pulmonary alveolar microlithiasis: no longer in the stone age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37259144" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : New insights in the genetic variant spectrum of SLC34A2 in pulmonary alveolar microlithiasis; a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14644915" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : A common pathway for the uptake of surfactant lipids by alveolar cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27200151" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Pulmonary Alveolar Microlithiasis - Clinico-Radiological dissociation - A case report with Radiological review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31831582" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Eight novel variants in the SLC34A2 gene in pulmonary alveolar microlithiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9258573" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Pulmonary alveolar microlithiasis: review of Italian reports.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15554073" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Pulmonary alveolar microlithiasis: report on 576 cases published in the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28626634" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : An unusual late onset of pulmonary alveolar microlithiasis: A case report and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31761429" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Pulmonary Alveolar Microlithiasis in Children Less than 5 Years of Age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1939772" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Pulmonary alveolar microlithiasis: CT findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27514591" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Pulmonary Alveolar Microlithiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32892884" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : A 35-Year-Old Woman With Progressive Dyspnea and Cough.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29636959" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Pneumothorax secondary to pulmonary alveolar microlithiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30086281" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Progressive Sandstorm Lung in Pulmonary Alveolar Microlithiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33434115" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Pulmonary Alveolar Microlithiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27618319" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Pulmonary Alveolar Microlithiasis: AIRP Best Cases in Radiologic-Pathologic Correlation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35771040" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : A Rare Case of Pulmonary Alveolar Microlithiasis with Diffuse Lung Uptake on Bone Scintigraphy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9654825" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Pulmonary alveolar microlithiasis: diagnosed by sputum examination and transbronchial biopsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7249778" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Bronchopulmonary lavage in alveolar microlithiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19660326" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Lung transplantation for pulmonary alveolar microlithiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20186308" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Lung transplantation for pulmonary alveolar microlithiasis: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26841075" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : A rare indication for lung transplantation - pulmonary alveolar microlithiasis: institutional experience of five consecutive cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20425862" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Long-term results of disodium etidronate treatment in pulmonary alveolar microlithiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Treatment of pulmonary alveolar microlithiasis with allendronate sodium
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9097354" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Pulmonary microlithiasis. Report of two cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12357485" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Pulmonary alveolar microlithiasis in childhood: clinical and radiological follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31235452" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Calcium-solubilizing sodium thiosulfate failed to improve pulmonary alveolar microlithiasis: Evaluation of calcium content with CT scan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22941890" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Pulmonary alveolar microlithiasis: two case reports and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16854698" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Pulmonary alveolar microlithiasis and pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19009221" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Pregnancy in a patient with severe pulmonary alveolar microlithiasis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15574274" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : [Diffuse pulmonary ossification associated with idiopathic pulmonary fibrosis].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28182861" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Diffuse Pulmonary Ossification in Fibrosing Interstitial Lung Diseases: Prevalence and Associations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/403873" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Diffuse pulmonary ossification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4525455" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Cyclic electrochemical inactivation and restoration of competence of bone matrix to transform fibroblasts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11426784" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Rare clinical diagnosis of dendriform pulmonary ossification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11426784" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Rare clinical diagnosis of dendriform pulmonary ossification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11426784" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Rare clinical diagnosis of dendriform pulmonary ossification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3263906" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Experimental heterotopic bone formation induced by bone morphogenetic protein and recombinant human interleukin-1B.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9754055" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Bone morphogenetic proteins--novel regulators of bone formation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14518672" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : A living case of pulmonary ossification associated with osteoclast formation from alveolar macrophage in the presence of T-cell cytokines.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15615988" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Diffuse high-attenuation pulmonary abnormalities: a pattern-oriented diagnostic approach on high-resolution CT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10459859" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8200985" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8992878" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27992976" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : [Idiopathic pulmonary hemosiderosis with dendriform pulmonary ossification].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27252231" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Dendriform pulmonary ossification in a patient with mucoepidermoid carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26431159" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Osteogenesis Imperfecta Associated with Dendriform Pulmonary Ossification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26407122" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : The Rapid Appearance and Disappearance of Dendriform Pulmonary Ossification after Diffuse Alveolar Hemorrhage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12870727" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Familial clustering of dendriform pulmonary ossification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27999676" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Recurrent pneumothorax related to diffuse dendriform pulmonary ossification in genetically predisposed individual.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28012500" id="rid128" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          129 : Familial diffuse pulmonary ossification: A possible genetic disorder.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33445645" id="rid129" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          130 : Quantitative Evaluation of Fibrosis in IPF Patients: Meaning of Diffuse Pulmonary Ossification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33959720" id="rid130" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          131 : Accelerated Pulmonary Ossification as a Sequela of SARS-CoV-2 Pneumonia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35293549" id="rid131" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          132 : Dendriform pulmonary ossification in coronavirus disease 2019 pneumonia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35835004" id="rid132" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          133 : Interstitial Pulmonary Fibrosis and Extensive Dendriform Ossification with Persistent Viral Load: A Rare Presentation of Post-COVID-19 Condition in Need of Lung Transplantation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26273537" id="rid133" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          134 : TGF-β/BMP signaling and other molecular events: regulation of osteoblastogenesis and bone formation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28981359" id="rid134" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          135 : Dendriform Pulmonary Ossification in the Absence of Usual Interstitial Pneumonia: CT Features and Possible Association With Recurrent Acid Aspiration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25316886" id="rid135" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          136 : Dendriform pulmonary ossification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25461781" id="rid136" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          137 : Selected case from the Arkadi M. Rywlin international pathology slide series: diffuse dendriform pulmonary ossification: report of 2 cases with review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31395268" id="rid137" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          138 : A 63-Year-Old Woman With Pulmonary Micronodules and Chronic Cough.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29321422" id="rid138" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          139 : Progressive Restrictive Ventilatory Impairment in Idiopathic Diffuse Pulmonary Ossification.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23417720" id="rid139" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          140 : Dendriform pulmonary ossification: unusual cause of spontaneous pneumothorax.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22307904" id="rid140" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          141 : Spontaneous pneumothorax in a patient with dendriform pulmonary ossification: report of a case.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3090992" id="rid141" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          142 : Diffuse pulmonary ossification and spontaneous pneumothorax in a pilot: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9850379" id="rid142" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          143 : Diffuse pulmonary ossification and recurrent spontaneous pneumothorax in a patient with bronchial asthma.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
